Emergent Biosolutions
EBS
EBS
297 hedge funds and large institutions have $2.53B invested in Emergent Biosolutions in 2018 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 106 increasing their positions, 105 reducing their positions, and 31 closing their positions.
Holders
297
Holders Change
+22
Holders Change %
+8%
% of All Funds
6.63%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
55
Increased
106
Reduced
105
Closed
31
Calls
$3.06M
Puts
$1.1M
Net Calls
+$1.97M
Net Calls Change
+$965K
Top Buyers
Top Sellers
1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$55.3M |
2 |
2
Aberdeen Group
Edinburgh,
United Kingdom
|
$46.1M |
3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$38.2M |
4 |
4
Renaissance Technologies
New York
|
$94.6M |
5 |
5
Goldman Sachs
New York
|
$47.2M |